These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 6611118
1. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography. Chase TN, Foster NL, Fedio P, Brooks R, Mansi L, Di Chiro G. Ann Neurol; 1984; 15 Suppl():S170-4. PubMed ID: 6611118 [Abstract] [Full Text] [Related]
2. Cortical abnormalities in Alzheimer's disease. Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G. Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378 [Abstract] [Full Text] [Related]
3. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB. Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432 [Abstract] [Full Text] [Related]
4. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126 [Abstract] [Full Text] [Related]
5. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB. CMAJ; 1986 Mar 15; 134(6):597-607. PubMed ID: 3512063 [Abstract] [Full Text] [Related]
6. Executive deficits and regional brain metabolism in Alzheimer's disease. Woo BK, Harwood DG, Melrose RJ, Mandelkern MA, Campa OM, Walston A, Sultzer DL. Int J Geriatr Psychiatry; 2010 Nov 15; 25(11):1150-8. PubMed ID: 20069587 [Abstract] [Full Text] [Related]
7. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism. Tamminga CA, Foster NL, Fedio P, Bird ED, Chase TN. Neurology; 1987 Jan 15; 37(1):161-5. PubMed ID: 2879258 [Abstract] [Full Text] [Related]
8. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J. J Nucl Med; 1994 Jan 15; 35(1):1-6. PubMed ID: 8271029 [Abstract] [Full Text] [Related]
9. Alzheimer's disease: focal cortical changes shown by positron emission tomography. Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G. Neurology; 1983 Aug 15; 33(8):961-5. PubMed ID: 6603596 [Abstract] [Full Text] [Related]
10. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Brain; 2016 Aug 15; 139(Pt 8):2275-89. PubMed ID: 27190008 [Abstract] [Full Text] [Related]
11. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Brain; 2012 Jul 15; 135(Pt 7):2115-25. PubMed ID: 22556189 [Abstract] [Full Text] [Related]
12. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, Rapoport SI. J Neurol Neurosurg Psychiatry; 1996 Feb 15; 60(2):158-67. PubMed ID: 8708645 [Abstract] [Full Text] [Related]
13. Regional cerebral glucose transport and utilization in Alzheimer's disease. Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF. Neurology; 1989 Nov 15; 39(11):1427-34. PubMed ID: 2812318 [Abstract] [Full Text] [Related]
14. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography. Salmon E, Gregoire MC, Delfiore G, Lemaire C, Degueldre C, Franck G, Comar D. J Cereb Blood Flow Metab; 1996 May 15; 16(3):399-408. PubMed ID: 8621744 [Abstract] [Full Text] [Related]
15. [Studies of cerebral blood flow and metabolism in patients with senile dementia of the Alzheimer's type and diagnostic evaluation of the dementing illnesses by positron emission tomography]. Sakamoto S. Nihon Ika Daigaku Zasshi; 1990 Jun 15; 57(3):222-34. PubMed ID: 2376611 [Abstract] [Full Text] [Related]
16. The functional neuroanatomy of verbal memory in Alzheimer's disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory. Staffaroni AM, Melrose RJ, Leskin LP, Riskin-Jones H, Harwood D, Mandelkern M, Sultzer DL. J Clin Exp Neuropsychol; 2017 Sep 15; 39(7):682-693. PubMed ID: 27876444 [Abstract] [Full Text] [Related]
17. Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positron emission tomography and psychometry. Sheridan PH, Sato S, Foster N, Bruno G, Cox C, Fedio P, Chase TN. Neurology; 1988 May 15; 38(5):747-50. PubMed ID: 3258970 [Abstract] [Full Text] [Related]
18. Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Salmon E, Collette F, Degueldre C, Lemaire C, Franck G. Hum Brain Mapp; 2000 May 15; 10(1):39-48. PubMed ID: 10843517 [Abstract] [Full Text] [Related]
19. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Friedland RP, Budinger TF, Koss E, Ober BA. Neurosci Lett; 1985 Feb 04; 53(3):235-40. PubMed ID: 3872424 [Abstract] [Full Text] [Related]